Intestine Transplant Outcomes

At a Glance

• First transplant: 08/22/2010
• Transplants performed in 2024: 2
• Total number of program transplants through 2024: 51
• Received Medicare approval: 2/8/2013

Outcomes

• Median time to transplant<: 5.3 months, compared with 10.5 months nationally
• Pre-transplant mortality~: .348 (expected .065, national .065)
• Transplant rates~: 1.84 (expected .939, national .563

Patient survival rates for multivisceral transplant:*

• Henry Ford one-year patient survival rate: 88.89%
• Henry Ford three-year patient survival rate: 50.00%

Graft survival rate for multivisceral transplant:+

• Henry Ford one-year graft survival rate: 88.89%
• Henry Ford three-year graft survival rate: 50.00%

~ Patients on the waitlist between 07/01/2022 and 06/30/2024.
*Estimated probability of surviving at one year, for patients receiving their first transplant between 7/01/2021 and 12/31/2023 and at three years, for patients receiving their first transplant between 1/01/2019 and 03/12/2020, and 06/13/2020 and 06/30/2021.
^ Adjusted for patient and donor characteristics.
+ Estimated probability of surviving with a functioning graft at one year, for patients receiving their first transplant between 7/01/2021 and 12/31/2023 and at three years, for patients receiving their first transplant between 1/01/2019 and 03/12/2020, and 06/13/2020 and 06/30/2021.

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available October 31, 2024, released January 7, 2025.

Milestones in Intestine and Multivisceral Transplantation

• First in Michigan to perform a modified multivisceral (stomach, intestinal and pancreas) transplant (2010)